Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Make Your 2024 Wish a Reality with Save the Children 2024-01-08 12:00
Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023 2024-01-08 09:00
2024 Trend Forecast for Cosmetic Surgery & Medical Aesthetics in Singapore 2024-01-08 09:00
Suvoda Announces 30% Growth in 2023 Driven by Strong Customer Adoption of New Suvoda Platform and Products 2024-01-08 08:00
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis 2024-01-08 07:00
Nuvilab Innovates Inpatient Nutrition with Food AI at Alexandra Hospital Singapore 2024-01-05 22:46
Supplemental New Drug Application for Akeso's Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer 2024-01-05 21:00
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio 2024-01-05 19:44
Grant of Restricted Share Units to Mr. Xing Jin 2024-01-05 19:00
Innovations in China's Greater Bay Area: Global Pitch Competition for Startups Announces Winners 2024-01-05 18:23
SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease 2024-01-05 16:00
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide 2024-01-05 14:35
Leading New Trends & Stimulating New Vitality, HNC Shenzhen 2023 Came to a Satisfactory Close. See You in Shanghai in 2024. 2024-01-05 10:10
UniFAHS Raises USD 1.4 Million in Seed Funding to Scale Bacteriophage Technology for Sustainable Agriculture 2024-01-05 10:00
Therabody, the Global Leader In Wellness Technology, Defends Against Recent Patent Infringement Lawsuit Filed by Hyperice 2024-01-05 06:33
Greenway Health Earns Frost & Sullivan's 2023 North American Revenue Cycle Management Customer Value Leadership Award for Consistently Delivering Products and Services that Enhance Health Providers and Patients Experiences 2024-01-05 04:30
Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications 2024-01-05 00:19
JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva® in Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024-01-04 21:40
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients 2024-01-04 21:11
Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA 2024-01-04 21:05
1 55 56 57 58 59 1534